The IMPT serves as the ‘communications and information hub’ for the field of multipurpose prevention technologies (MPTs).

Our resource center features a searchable database, providing you access to global MPT research, technical webinars, trainee and career resources, advocacy tools, and more. Search our resources!

Resource Search

Search Results

MPTs & the IMPT Platform

MPTs & the IMPT Platform

MPTs & the IMPT Platform May 2021 The MPTs & the IMPT Platform is a PowerPoint presentation created by the IMPT Secretariat at CAMI Health to help our colleagues integrate MPTs into their talks and presentations. Please email IMPT@cami-health.org with any feedback on how you used this information. Download the presentation slide deck CAMI Health […]

IMPT, CAMI Health May 2021
TRIO Study Brief:  Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think

TRIO Study Brief: Long-Acting Injections for Women’s HIV Prevention in Sub-Saharan Africa: What End-Users Think

RTI International | Women’s Global Health Imperative; Impact Research and Development Organization, Kenya; Setshaba Research Centre, South Africa; The Initiative for MPTs (IMPT) February 2021

Annual National Reproductive Health Conference

10-13 August 2021 Annual National Reproductive Health Conference San Francisco, CA, USA

Visit Convening August 2021
Toxicity study considerations for HIV prevention and MPT R&D

Toxicity study considerations for HIV prevention and MPT R&D

The IMPT, Thomas Moench, Miles Brennan May 2021
Combining Active Pharmaceutical Ingredients: MPT Development & Regulatory Considerations

Combining Active Pharmaceutical Ingredients: MPT Development & Regulatory Considerations

The IMPT, Certara, Deven Shah, Kevin Hershberger, Tamra Goodrow June 2021
Integrating Socio-behavioral & Market Research into MPT R&D: Applying Lessons Learned

Integrating Socio-behavioral & Market Research into MPT R&D: Applying Lessons Learned

The IMPT, Deborah Anderson, Mary Weitzel, Betsy Tolley, Matthew Quaife, Khatija Ahmed, Joseph Murungu, Bethany Young Holt March 2021
A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial

A novel vaginal pH regulator: results from the phase 3 AMPOWER contraception clinical trial

Thomas, M.; Chappell, B.T.; Maximos, B.; Cullwell, K.; & Howard, B. July 2020
The role of cervicovaginal microbiota on contraceptive and MPT development

The role of cervicovaginal microbiota on contraceptive and MPT development

The IMPT, Jacques Ravel, Jennifer Deese December 2020
Bridging the gap: Advancing multipurpose prevention technologies from the lab into the hands of women

Bridging the gap: Advancing multipurpose prevention technologies from the lab into the hands of women

Young Holt, B., Kiarie, J., Kopf, G., Nanda, K., Hemmerling, A., & Achilles, S. May 2020
23rd International AIDS Conference (AIDS 2020: Virtual)

23rd International AIDS Conference (AIDS 2020: Virtual)

International AIDS Society (IAS) July 2020
The Case for MPTs

The Case for MPTs

The Case for MPTs 2019 click to view Factsheet / Outreach Material In this Factsheet / Outreach Material: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): Other or N/A Topic(s): Education MPTs Reproductive Health Region(s): Global

CAMI Health Visit Outreach Material January 2019
Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introducion

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introducion

Market Access Framework for Multipurpose Prevention Technology (MPT) Development and Introducion April 2019 click to view Technical Brief In this Technical Brief: Health Risk(s): HIV STI / STD Unintended Pregnancy Product Type(s): MPTs Topic(s): MPTs Product Development Product Trials

Dellplain, L., Young Holt, B., Hemmerling, A., Romano, J., van der Straten, A., & Turpin, J. Visit Technical Brief April 2019
Market Access Framework for MPT Development

Market Access Framework for MPT Development

This framework is intended to serve as a resource to inform product development and investment decision-making that is focused specifically on market access components of MPT development and introduction—in other words, activities that are critical to ensuring that MPTs in development are not only efficacious in clinical trials, but also desired, acceptable, and accessible to […]

(IMPT) Initiative for Multipurpose Prevention Technologies Visit Technical Brief April 2019